Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12090200 Methods of producing cells resistant to HIV infection

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
November 4, 2020
0
Date of Patent
September 17, 2024
0
Patent Application Number
17089468
0
Patent Citations
‌
US Patent 8287857 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
0
‌
US Patent 8993532 Structurally designed shRNAs
0
‌
US Patent 9522176 MRNA therapy for phenylketonuria
0
‌
US Patent 9527904 Delivery of proteins using adeno-associated virus (AAV) vectors
0
‌
US Patent 9834790 Methods and compositions for the activation of gamma-delta T-cells
0
‌
US Patent 9834791 CRISPR-related methods and compositions with governing gRNAS
0
‌
US Patent 9914938 Methods and compositions for the activation of gamma-delta T-cells
0
‌
US Patent 10023880 Methods and compositions for the activation of gamma-delta T-cells
0
‌
US Patent 10036038 HIV pre-immunization and immunotherapy
0
‌
US Patent 10036040 Methods and compositions for the activation of gamma-delta T-cells
0
•••
Patent Inventor Names
Haishan Li
0
Tyler Lahusen
0
Charles David Pauza
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12090200
0
Patent Primary Examiner
‌
Nicole Kinsey White
0

Find more entities like US Patent 12090200 Methods of producing cells resistant to HIV infection

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.